title: Automated closed loop control of inspired oxygen concentration.
abstract: Oxygen therapy is extensively used in premature infants and adults with respiratory insufficiency. In the premature infant the goal during manual control of the F(IO(2)) is to maintain adequate oxygenation and to minimize the exposure to hypoxemia, hyperoxemia, and oxygen. However, this is frequently not achieved during routine care, which increases the risks of associated side effects affecting the eye, lungs, and central nervous system. In the adult the primary goal is to avoid hypoxemia, but conventional methods of oxygen supplementation may fall short during periods of increased demand. On the other hand, there are growing concerns related to unnecessarily high F(IO(2)) levels that increase the exposure to hyperoxemia and excessive oxygen use in settings where resources are limited. Systems for automated closed loop control of F(IO(2)) have been developed for use in neonates and adults. This paper will give an overview of the rationale for the development of these systems, present the evidence, and discuss important advantages and limitations.
authors.affiliation: Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida 33101, USA. nclaure@miami.edu
authors.forename: Nelson
authors.initials: N
authors.lastname: Claure
authors.forename: Eduardo
authors.initials: E
authors.lastname: Bancalari
mesh_terms: D000328:Adult; D000465:Algorithms; D006801:Humans; D018496:Hyperoxia / Q000517:prevention & control; D000860:Hypoxia / Q000517:prevention & control; D007231:Infant, Newborn; D010092:Oximetry; D010100:Oxygen / Q000008:administration & dosage / Q000097:blood*; D010102:Oxygen Inhalation Therapy / Q000295:instrumentation*; D047928:Premature Birth / Q000628:therapy; D012121:Respiration, Artificial / Q000295:instrumentation; D012131:Respiratory Insufficiency / Q000628:therapy*
chemical_list: D010100:Oxygen